Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: history of present illness: the patient is a 64-year-old woman, status post autologous liver transplant on for primary sclerosing cholangitis, diabetes type ii. she came in for a visit at the clinic center today, one day after falling on the floor at home landing on her ribs and forehand. the patient reports no loss of consciousness, lightheadedness, chest pain, shortness of breath at this time. she did report that her legs have been feeling very weak lately. the patient was helped to her feet by her brother and the patient resumed her activities for the day without complaint. today, the patient complained of significant pain in her left lower ribs. the patient also reports having decreased appetite since discharge. no nausea or vomiting, positive flatus, positive bowel movement, describes "not liking the sight of food". the patient has a recent hospital admission on to . the patient's diagnosis was end-stage liver disease, status post orthotopic liver transplant followed by duplex ultrasound revealing normal arterial and venous flow, cholangiogram revealing no stricture or lesion of the biliary system. condition at the time of discharge was stable. she was discharged to home without services. at the time, she was on mmf 1,000 b.i.d., prednisone 15 q d, inderal 275 b.i.d. past medical history: status post autologous liver transplant 06/. primary sclerosing cholangitis, status post stents. diabetes type 2. hyperthyroidism. gastroesophageal reflux disease. diverticulosis. laminectomy. appendectomy. cholecystectomy. ulcerative colitis. brca status post mastectomy and chemotherapy. medications on admission: 1. ativan 0.5 mg p.r.n. 2. fluoxetine 60 mg q d. 3. levothyroxine 150 mg q d. 4. multivitamin, one q d. 5. alendronate 70 mg q week. 6. bactrim ss, one q d. 7. fluconazole 400 mg q d. 8. lispro, one unit q.i.d. ss. 9. lantus 12 units q p.m. 10. mmf 1,000 11. protonix 40 mg q d. 12. valcyte 450 b.i.d. 13. prednisone 15 q d. 14. neoral 275 b.i.d. 15. furosemide 20 q d. physical examination: on admission, she was in no apparent distress. she was alert and oriented times three. cranial nerves ii-xii were intact. pupils equal, round and reactive to light. extraocular movements intact. moist mucous membranes. regular rate and rhythm with 1-2/6 diastolic rolling murmur. clear to auscultation bilaterally. exquisitely tender along the left lateral lower costal margin. abdomen was nondistended, normal abdominal examination, soft, nontender, well healing incision with staples in place, no erythema or signs of drainage. extremities: dorsalis pedis was present, no edema. vital signs on admission: temperature 97.1, blood pressure 123/65. laboratory data: hematocrit 28.5, white blood cell count 14.9, platelets 419, sodium 131, potassium 6.7, chloride 98, bicarbonate 20, bun 59, creatinine 2.2, glucose 308, calcium 9.6, phosphate 5.4, magnesium 2.7, asg 28, alt 44, alkaline phosphatase 148, total bilirubin 3.5, pt 13.3, ptt 25.5, inr 1.2, fibrinogen 504. her first cyclosporin level for the next day was 1,330. she was continued on prednisone 15 q d. she was put on 275 b.i.d. for the first two doses and after the level, she was held one dose and then started on 200. the repeated mostly held with occasional dosing with levels slowly declining from 1,000 to 540 by . hospital course: status post fall. the patient came with confusion. she developed respiratory insufficiency and decreasing mental status with changes. she required intubation. she had developed ascites and hydrothorax, which were drained. despite a normal ultrasound on admission, magnetic resonance imaging showed portal vein thrombosis. she received tpa times three and wall stenting of the portal vein and flow was reestablished. there was still some clot in the superior mesenteric vein. her symptoms decreased and she improved clinically. her ascites resolved as she became ambulatory while requiring tube feeds presently. it is possible that she no longer will require the tube feeds. pain is well controlled on oral medication. regarding cultures, on , she had a blood culture that is negative. on , she has a bal that was negative. she received several methicillin resistant staphylococcus aureus screenings, which were negative on . on , cultures through her hospital stay have failed to grow anything or show anything of clinical significance. on , the patient received mr contrast mrcp so she had the mr of the abdomen with and without contrast and reconstruction for indications status post recent liver transplant and elevated alkaline phosphatase. impression was portal vein thrombosis from confluence of the imv this point being higher up, mild to moderate intrahepatic biliary ductal dilatation with no fixed filling defect and no strictures seen. the patient was discharged to the , which is an extended care facility. discharge instructions: they are to monitor her for the following: fevers, chills, nausea, vomiting, inability to tolerate food or drink. if any of these occurs, they are to contact the physician immediately or their in-house physician if they are unable to reach. final diagnoses: portal vein thrombosis, hydrothorax, thorax respiratory insufficiency requiring intubation. comorbidities: diabetes type 2, hypothyroidism, ulcerative colitis, gastroesophageal reflux disease, diverticulitis, cholecystectomy, laminectomy, appendectomy, breast cancer status post chemotherapy and mastectomy. follow up: liver clinic at 10:20 a.m. dr. at 2:10 p.m. liver clinic at 9:20 a.m. phone number for the clinic is and the same for dr. . procedures performed: chest tube and intubation. condition on discharge: afebrile and tolerating a regular diet. pain well controlled on oral medications. discharge medications: 1. levothyroxine sodium 150 mcg tablets, one tablet p.o. q d. 2. alendronate 70 mg tablets, one tablet p.o. q week fridays. 3. bactrim ss tablets, one tablet p.o. q d. 4. multivitamin. 5. lansoprazole 30 mg capsules delayed release, one capsule p.o. q d. 6. artificial tear ointment. 7. polyvinyl alcohol drops. 8. albuterol nebs. 9. fluconazole 200 mg tablets, one tablet p.o. q 24 hours. 10. visicol 10 suppository h.s. as needed. 11. ipratropium bromide nebs as needed. 12. docusate 100 mg, one capsule p.o. b.i.d. 13. valganciclovir 450 mg tablets, one tablet p.o. q d. 14. spironolactone 25 mg tablets, one tablet p.o. q d. 15. acetaminophen. 16. lorazepam 0.5 mg tablets p.o. b.i.d. as needed for anxiety. 17. fluoxetine hcl 20 mg capsules, one capsule p.o. q d. 18. sliding scale insulin. 19. warfarin. she should take 0.5 mg every day. 20. mycophenolate mofetil 200 suspension for reconstitution 2.5 p.o. q d four times a day, which is 500 mg four times a day. 21. prednisone 5 mg tablets. take two tablets p.o. q d, which is 10 mg every day. , md, phd procedure: venous catheterization, not elsewhere classified continuous invasive mechanical ventilation for 96 consecutive hours or more spinal tap incision of lung parenteral infusion of concentrated nutritional substances insertion of endotracheal tube enteral infusion of concentrated nutritional substances angioplasty of other non-coronary vessel(s) injection or infusion of thrombolytic agent arteriography of femoral and other lower extremity arteries closed (percutaneous) [needle] biopsy of liver venous catheterization for renal dialysis percutaneous abdominal drainage arteriography of other intra-abdominal arteries insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s) diagnoses: unspecified pleural effusion urinary tract infection, site not specified acute kidney failure, unspecified acute respiratory failure liver replaced by transplant portal vein thrombosis 

Answer: The patient is high likely exposed to